Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?

Company Overview - Acurx Pharmaceuticals, Inc. (ACXP) is part of the Medical sector, which includes 925 individual stocks and currently holds a Zacks Sector Rank of 10 among 16 groups [2] - The company is categorized under the Medical - Biomedical and Genetics industry, which consists of 444 companies and is ranked 140 in the Zacks Industry Rank [6] Performance Metrics - Acurx Pharmaceuticals has returned 93.2% year-to-date, significantly outperforming the average loss of 3.2% in the Medical group [4] - The Zacks Consensus Estimate for ACXP's full-year earnings has increased by 42.5% over the past quarter, indicating a positive trend in analyst sentiment [4] Comparative Analysis - Another stock in the Medical sector, Apyx Medical (APYX), has returned 4.9% year-to-date and has a Zacks Rank of 2 (Buy) [5] - Apyx Medical belongs to the Medical - Products industry, which has seen a decline of 10.3% this year, contrasting with Acurx's strong performance [7]